Home > Insider Trading > Filing (0001209191-11-033762)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267602	Alimera Sciences Inc	ALIM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1489531	Kenneth Green	6120 Windward Parkway Suite 290 Alpharetta GA 30005	Svp & Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-06-07	14,028	$1.33	14,028	No	4	M	Direct
Common Stock	Acquisiton	2011-06-07	7,941	$1.33	21,969	No	4	M	Direct
Common Stock	Disposition	2011-06-07	21,969	$8.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-06-07	14,028	$0.00	14,028	$1.33
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-06-07	7,941	$0.00	7,941	$1.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,031		2016-10-12	No	4	M	Direct
36,177		2016-10-12	No	4	M	Direct

Footnotes

Exercisable with respect to 1/4 of the shares of stock which are subject to this option on 11/22/07 (the "Initial Vesting Date"), provided Employee remains continuously employed by Alimera through the Initial Vesting Date; and 3/4 of the shares of stock which are subject to this option in equal increments quarterly over three years beginning on the date three (3) months from the Initial Vesting Date provided he or she remains continuously employed by Alimera through the last day of each quarterly period.
Exercisable with respect to 1/4 of the shares of stock which are subject to this option on 11/22/06 (the "Initial Vesting Date"), provided Employee remains continuously employed by Alimera through the Initial Vesting Date; and 3/4 of the shares of stock which are subject to this option in equal increments quarterly over three years beginning on the date three (3) months from the Initial Vesting Date provided he or she remains continuously employed by Alimera through the last day of each quarterly period.